Valneva Shares Tick Higher After COVID-19 Vaccine Supply Pact With Bahrain

Valneva SE VALN has signed an advance purchase agreement with the Kingdom of Bahrain to supply one (1) million doses of its inactivated COVID-19 vaccine candidate VLA2001. 

• This is the second purchase agreement Valneva has secured for VLA2001 since reporting data for its Phase 3 trial Cov-Compare.
• Valneva has initiated a rolling submission process with the Bahraini National Health Regulatory Authority.
• The Company plans to start deliveries in the Q1 of 2022.
• Last month, Valneva announced that the European Commission signed an advanced purchase agreement for up to 60 million doses of VLA20011. 
• Related Link: Valneva's COVID-19 Shot Fails As Booster In Pfizer/BioNTech Vaccinated Population.
• Price Action: VALN shares are up 13.3% at $54.38 during the premarket session on the last check Wednesday.